Biosimilars: A Excessive‑worth Alternative
Alternate options to biologic medicines, often known as biosimilars, supply the identical security and effectiveness as the unique medication, and just like generic medication, they drive market competitors.
Why this issues to your plan:
- Biosimilars introduce market competitors, driving down costs.
- They provide extra value‑efficient therapy choices for situations like most cancers, rheumatoid arthritis, and Crohn’s illness.
- IBX employs most popular drug methods and unique contracting with biosimilar producers to maximise value financial savings.
- We’re actively monitoring and figuring out alternatives to leverage biosimilars to maximise our value financial savings alternatives for our shoppers.
Web site of Care: Accountable Steering
Considered one of our strongest instruments in combatting rising specialty drug prices on the medical profit is managing the positioning of care by means of our MCES program. For a lot of specialty medication administered by a well being care skilled, administration in a physician’s workplace, infusion clinic, or within the house by way of a nurse will not be solely extra handy to the member, but additionally considerably reduces prices.
The MCES program has saved over $250 million since 2012. Our Utilization Administration procedures and supplier contracting facilitate website of care coordination and considerably cut back the added prices related to the administration of excessive‑value medical specialty medication.
What This Means for You
As an employer, you need to supply advantages that meet the evolving wants of your staff with out compromising plan sustainability. IBX helps you with:
